Eric Veiel
Head of Global Investments and Chief Investment Officer at T. Rowe Price Group
Thanks, Jen. For the second year in a row, we saw strong gains in most equity markets, particularly in the US where technology stocks continue to drive returns. Fixed-income markets were more muted for the year and were characterized by a significant interest-rate volatility with short rates falling in the long-end of the curve rising. Equity market performance in 2024 saw similar themes to 2023 as large technology stocks continued to lead on the back of the growing impact of artificial intelligence, strong earnings momentum and expanding valuation.
The extreme narrowness in-markets continued in 2024 as eight stocks drove 60% of the S&P 500's return. Our research also showed a significantly high-level of factor volatility during the year within equity markets despite the overall level of equity market volatility as measured by the VICS remaining low. This type of market environment makes it more difficult for our strategies to outperform, given our -- given our disciplined focus on fundamentals and valuation and our emphasis on the long-term. Across asset classes, 54% of our funds beat their peer group medians for the year and on an asset-weighted basis, 61% beat their peer groups.
In our equity franchise, despite mixed performance overall, I'm encouraged by the evidence that our research process and teams remain very strong. Our flagship US equity research strategy delivered another year of top-quartile performance and outperformed the S&P 500 by 140 basis-points net of fees. A number of our sector products also delivered strong performance with science and technology, communications and technology, New ERA, , financial services and global technology, all top-quartile performers for the year. These strong underlying strategy results translated into top-quartile performance across a number of key diversified strategies, including mid-cap value, blue-chip growth and diversified mid-cap growth. However, results were below our high expectations in a number of strategies, including mid-cap growth, New Horizons, dividend growth in emerging markets equity. Our teams remain highly focused on improving performance in these and all of our strategies. I will also take the opportunity to highlight that for the 17th consecutive year, one of our flagship funds managed by David Jeru beat its Morningstar peer group. This is the longest streak of outperformance versus its Morningstar peers among any US equity or multi-asset fund under the same portfolio manager. This is not the only example of performance consistency. It's evident in a number of our products and across asset classes. In addition to capital appreciation managed by Jeru, US equity research, mid-cap value, institutional floating-rate, Maryland tax rebound and the 2015 and 2020 vintages of our retirement funds all delivered top-decile performance for the three, five and 10-year time periods. Our broad target date franchise continued to deliver strong performance over multiple time periods. On an asset-weighted basis, 73% of our target date assets beat their peer group medians for both the one and three-year time periods and over 90% were top-quartile for the five, 10 and the 15-year time periods. In our fixed-income division, a number of our muni strategies as well as our short-duration income, institutional floating-rate and global high-income products had top-quartile one-year performance. Conversely, our high-yield and international bond products had a more challenging year with performance lagging peers and benchmarks. And in our ETFs, three of our fixed-income ETFs, ultra short-term bond, US high-yield and floating-rate, all had top-quartile one-year performance, while the other two fixed-income ETFs with one-year performance beat their peer medians. Returns across alternative strategies were generally positive in the 4th-quarter. Structured credit generated the strongest returns while liquid strategies track the overall market backdrop. Private market strategies experienced greater dispersion with private credit performing ahead of special situations and distressed strategies. I've shared a few highlights related to investment performance. Now I'll turn to several important initiatives we've advanced in 2024. Last year brought exciting growth in our ETF business. We started the year with $2.5 billion in AUM and as Rob mentioned, we closed the year with just under $8 billion in AUM. In the 4th-quarter, we filed to launch the capital appreciation premium income ETF, which will be managed by David Jerus and his team and the hedged equity ETF, which will be managed by our multi-asset team and we expect to bring these to-market this spring. We are considering additional strategies to offer clients in this tax-efficient wrapper and expect further launches throughout 2025 and 2026. As the largest provider of active target date products and an industry-leader in retirement, we are always focused on anticipating and evolving client needs and expanding our offerings to meet them. In 2024, we extended the target date range to include personalized Retirement Manager or PRM as well as a managed lifetime income product. PRM is a service that uses personal data to create a unique asset allocation tailored to an individual specific saving goals, preferences and financial situation to help drive better retirement outcomes. Our managed Lifetime income product combines a managed payout product with the qualifying longevity and annuity Contract or QLAC from Pacific Life to offer retirees stable and predictable monthly income for life. We're also seeing continued success with our blend products, which we designed to meet the needs of price-sensitive clients who are interested in our Target date expertise. Looking-forward, we are exploring how alternatives could be used in our Target date products if or when regulatory hurdles come down and client demand materializes. We've been managing integrated equity strategies for nearly two decades, combining fundamental and quantitative processes with our deep portfolio construction expertise. Our 12-person integrated equity team manages about $12 billion across a range of integrated equity products, including US small, mid and large-cap and global and international equity. In 2024, we added an equity solutions portfolio manager who works closely with our clients to deliver customized solutions. We closed the year with over $1 billion in equity solutions AUM and several other opportunities advancing in the pipeline. Another way we've looked to deliver alpha for our clients has been through allocations to late-stage pre-IPO private companies in our US Fordiac mutual Funds and other pool products, which we've been doing since 2007. As one of the most active prominent managers of small and mid-cap equities, we've built a network of established relationships to put our team at the forefront of emerging investment opportunities. Our private-equity capability can draw on the expertise of over 230 global research analysts immersed in their industries and regions. At year-end, over 25 of our investment strategies were invested in privates. We are now exploring new ways to move beyond the 40 act fund structure to offer this capability to more clients in a dedicated product. Our US equity research strategy with over 25 Price associate analysts contributing to the portfolio in their focus area of expertise demonstrates the strength of our research platform across the breadth of the market and our pipeline of investment talent. Clients are responding to our rules-based portfolio construction and risk management that isolates our analyst stock selection skill as the alpha driver. In addition to the consistent long-term performance I mentioned previously, we saw strong gross sales to this strategy in 2024. We've broadened the equity research franchise with international and global equity research strategies, which mirror the time-tested approach of our US equity strategy. These newer strategies hit their three-year track records in September of 2024. In addition, we are developing a small and mid-cap structured research capability within our TRO Price Investment Management Advisor that we plan to cede this year. We formed the TRO Price Investment Institute with the overarching mission of creating a center of excellence within investments that focuses on our clients and our investors. Led by Justin Thompson, the Institute will enhance our offer to clients beyond investment performance through differentiated thought leadership, client training and other value-added experiences for clients that showcase our investment and research capabilities, we will assist with their investment decision-making and ultimately help drive enhanced commercial outcomes for us. The institute will also help to support our global investment team, the heart of our investment capability with wide-ranging investment skills training from analyst best practices to portfolio construction. With Justin's new role, we took the opportunity to review our equity organization and have combined our US equity and international equity divisions into one global equity division. This allows us to build-on our strengths to ensure we maximize our investment performance, attract, develop and retain the highest caliber of talent, maximize our efficiency and optimize our commercial success. Josh Nelson has assumed the role of Head of Global Equity. 2024 was first year as Head of Global Fixed income and momentum is building across the franchise. On an asset-weighted basis, 65% of our fixed-income assets outperformed their peer groups in 2024, and we had $12.6 billion in positive net flows to fixed-income, bringing our fixed-income AUM to $188 billion at the end-of-the year. We've made a concerted and fruitful push into the insurance sector and fixed-income is the main asset class of interest for these clients. It is this insurance channel that drove much of our strong fixed-income flows in Q2 and Q4 of 2024. Our fixed-income team is also upgrading the tools our investors use and working with our distribution teams to ensure we have the sales and support staff to further enable our fixed-income growth. We have been building capabilities in data science, machine-learning and predictive models since 2017. Our approach has always been one of intelligent augmentation, enabling our investors with additional data points to aid their decision-making and to unlock productivity gains. We now have 280 investors using our AI tool, investor copilot, a, a custom chatbot embedded within the private environment of our research platforms to summarize proprietary research and service insights. We believe generative AI technology is still nascent in its capabilities to add material lift to common tasks in investment research, but that there is potential to add material business value as the technology and our use cases mature. I'm pleased with the progress we made in 2024 and that we made this progress while staying firmly rooted in our three pillars of people, process and culture. We remain singularly focused on pursuing investment excellence for our clients, and I'm confident we have the right team and resources in-place. With that, I'd like to ask the operator to open the line for questions.